 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Quest Launches TERC MDx to Identify Women at High Risk of Cervical Cancer after Uncertain Pap Test
September 12, 2012
Quest Launches TERC MDx to Identify Women at High Risk of Cervical Cancer after Uncertain Pap Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Citing Validation Costs, IP Concerns, Reference Labs Offer Gloomy Take on Protein Biomarker Tests
May 25, 2012 / ProteoMonitor - Lung Cancer Study Highlights Current Limitations of MALDI Mass Spec
July 22, 2011 / ProteoMonitor - NCI's Early Detection Research Network Running Trials to Compare Biomarker-Based Cancer Diagnostics
April 22, 2011 / ProteoMonitor - New Kennedy/Eshoo Personalized Medicine Bill Tackles Hot Topics in PGx
June 2, 2010 / Pharmacogenomics Reporter - Q&A: CDC's Khoury Discusses GAPPNet's Strategy to Drive Adoption of Personalized Medicine
July 15, 2009 / Pharmacogenomics Reporter